EDIT
Price
$2.54
Change
-$0.02 (-0.78%)
Updated
Jul 7, 04:59 PM (EDT)
Capitalization
215.14M
23 days until earnings call
OSRH
Price
$1.33
Change
-$0.02 (-1.48%)
Updated
Jul 7, 04:59 PM (EDT)
Capitalization
26.02M
Interact to see
Advertisement

EDIT vs OSRH

Header iconEDIT vs OSRH Comparison
Open Charts EDIT vs OSRHBanner chart's image
Editas Medicine
Price$2.54
Change-$0.02 (-0.78%)
Volume$15.17K
Capitalization215.14M
OSR Holdings
Price$1.33
Change-$0.02 (-1.48%)
Volume$300
Capitalization26.02M
EDIT vs OSRH Comparison Chart in %
Loading...
EDIT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OSRH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EDIT vs. OSRH commentary
Jul 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EDIT is a Buy and OSRH is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 08, 2025
Stock price -- (EDIT: $2.57 vs. OSRH: $1.39)
Brand notoriety: EDIT and OSRH are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EDIT: 82% vs. OSRH: 7%
Market capitalization -- EDIT: $212.63M vs. OSRH: $26.34M
EDIT [@Biotechnology] is valued at $212.63M. OSRH’s [@Biotechnology] market capitalization is $26.34M. The market cap for tickers in the [@Biotechnology] industry ranges from $316.35B to $0. The average market capitalization across the [@Biotechnology] industry is $2.39B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EDIT’s FA Score shows that 0 FA rating(s) are green whileOSRH’s FA Score has 1 green FA rating(s).

  • EDIT’s FA Score: 0 green, 5 red.
  • OSRH’s FA Score: 1 green, 4 red.
According to our system of comparison, EDIT is a better buy in the long-term than OSRH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EDIT’s TA Score shows that 3 TA indicator(s) are bullish while OSRH’s TA Score has 5 bullish TA indicator(s).

  • EDIT’s TA Score: 3 bullish, 4 bearish.
  • OSRH’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, OSRH is a better buy in the short-term than EDIT.

Price Growth

EDIT (@Biotechnology) experienced а +21.23% price change this week, while OSRH (@Biotechnology) price change was +11.20% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.35%. For the same industry, the average monthly price growth was +13.82%, and the average quarterly price growth was -0.82%.

Reported Earning Dates

EDIT is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Biotechnology (+5.35% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EDIT($215M) has a higher market cap than OSRH($26M). EDIT YTD gains are higher at: 102.362 vs. OSRH (-87.944). OSRH has higher annual earnings (EBITDA): -10.11M vs. EDIT (-244.52M). EDIT has more cash in the bank: 221M vs. OSRH (1.6M). OSRH has less debt than EDIT: OSRH (4.78M) vs EDIT (31.1M). EDIT has higher revenues than OSRH: EDIT (35.8M) vs OSRH (-148.95K).
EDITOSRHEDIT / OSRH
Capitalization215M26M827%
EBITDA-244.52M-10.11M2,419%
Gain YTD102.362-87.944-116%
P/E RatioN/AN/A-
Revenue35.8M-148.95K-24,034%
Total Cash221M1.6M13,847%
Total Debt31.1M4.78M651%
FUNDAMENTALS RATINGS
EDIT: Fundamental Ratings
EDIT
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
40
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
95

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
EDITOSRH
RSI
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
3%
Stochastic
ODDS (%)
Bearish Trend 5 days ago
89%
Bullish Trend 5 days ago
44%
Momentum
ODDS (%)
N/A
Bearish Trend 5 days ago
22%
MACD
ODDS (%)
Bullish Trend 5 days ago
78%
Bearish Trend 5 days ago
7%
TrendWeek
ODDS (%)
Bullish Trend 5 days ago
78%
Bullish Trend 5 days ago
43%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
78%
Bullish Trend 5 days ago
39%
Advances
ODDS (%)
Bullish Trend 5 days ago
77%
Bullish Trend 8 days ago
58%
Declines
ODDS (%)
Bearish Trend 12 days ago
89%
Bearish Trend 5 days ago
69%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
84%
Bearish Trend 5 days ago
14%
Aroon
ODDS (%)
Bullish Trend 5 days ago
76%
Bullish Trend 5 days ago
30%
View a ticker or compare two or three
Interact to see
Advertisement
EDIT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OSRH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KENS0.260.16
+152.94%
Kenilworth Systems Corp.
ORPB7.89N/A
N/A
Oregon Pacific Bancorp
RPHCF14.72N/A
N/A
Rohto Pharmaceutical Co.
SDRMF2.86N/A
N/A
SITEMINDER LTD
CLPBY9.36-0.12
-1.27%
Coloplast AS

EDIT and

Correlation & Price change

A.I.dvisor indicates that over the last year, EDIT has been loosely correlated with CRSP. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if EDIT jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EDIT
1D Price
Change %
EDIT100%
+0.39%
CRSP - EDIT
55%
Loosely correlated
+0.97%
NTLA - EDIT
49%
Loosely correlated
+0.09%
ABCL - EDIT
48%
Loosely correlated
+1.33%
PRME - EDIT
48%
Loosely correlated
+1.30%
RXRX - EDIT
47%
Loosely correlated
+1.15%
More

OSRH and

Correlation & Price change

A.I.dvisor tells us that OSRH and MIST have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OSRH and MIST's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OSRH
1D Price
Change %
OSRH100%
N/A
MIST - OSRH
29%
Poorly correlated
+1.04%
EDIT - OSRH
24%
Poorly correlated
+0.39%
EDSA - OSRH
22%
Poorly correlated
+1.96%
VERA - OSRH
21%
Poorly correlated
N/A
IFRX - OSRH
20%
Poorly correlated
-1.06%
More